Fast Track the Cure Enters Second Phase with New Global Partners to Accelerate Access to Six-Month DR-TB Treatments
The Fast Track the Cure initiative is proud to enter its next phase with its support of a new group of community-based partners. This chapter brings together powerful voices from across the globe, including ASPAT (Peru), Dopasi Foundation (Pakistan), Nari Maitree (Bangladesh), REACH (India), and TB Network (Nigeria).
TB and #6MonthsMax Treatments Featured Prominently in Dr. Tedros' Address at WHA78
The Seventy-eighth World Health Assembly opened with a powerful speech from Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, highlighting key milestones in global health, including the impact of six-month DR-TB treatments.
Papua New Guinea Expands Access to Six-Month, All-Oral Treatment for Drug-Resistant Tuberculosis
Papua New Guinea (PNG) has begun rolling out the six-month, WHO-endorsed BPaL/M treatment regimens for DR-TB. This change is expected to improve treatment experiences and outcomes, and save money.
Breakthrough in Tuberculosis Treatment: Major Price Cuts for Life-Saving Drugs
25% price reduction of key DR-TB drug, pretomanid, announced by TB Alliance, Lupin Limited, and Stop TB Partnership’s Global Drug Facility (GDF). Pretomanid price falls below $1 per day; BPaLM price falls below $2 per day.
Announcing New Fast Track the Cure Blog; News Archives Found here
Fast Track the Cure will now be covering news blog style — offering its own perspectives on global developments relating to expanding access to faster, safer, more effective TB cures. Link to news archive can be found here.